Mayo Clinic

All recorded activity

By stage

Series A2

Series C+2

Pre-seed1

Series B1

Undisclosed1

Healthtech5

Biotech2

United States6

Netherlands1

7 in all activity

Jul 22

AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases

$24MSeries A

Role not disclosed

Jun 21

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

$14.4MSeries A+

Role not disclosed

Apr 30

Provides AI-powered digital diagnostics for anatomic and clinical pathology

$15MUndisclosed

Role not disclosed

Mar 31

Develops implantable lymphatic drainage system to manage lymphedema

$1.5MPre-Seed

Role not disclosed

Mar 31

Provides wearable health monitoring and personalized health insights

$575MSeries G

Role not disclosed

Mar 10

Develops autonomous robotic phlebotomy devices for diagnostic blood collection

$70MSeries B

Role not disclosed

Jan 21